What do individuals in different science groups within a life sciences organization think about genetic modification?
An assessment was undertaken of the attitudes of individuals within the science community towards a program to produce genetically modified cattle for altered milk composition, expectantly allowing for research into the treatment of multiple sclerosis in humans. The majority of respondents to an electronic survey expressed favorable attitudes to the program, thought it beneficial, respected individual freedom and was fair and just and disagreed that it was harmful. A passion for science and having a suitable lifestyle were the most important motivating factors for individuals. Finally, there were a wide range of responses to a number of cultural beliefs or myths. Science grouping significantly affected the responses. Compared with Systems and Land groups, Plant and Reproduction groups more strongly agreed with the project, thought it less harmful to interest groups, felt that genetic modification of animals was more morally acceptable, and more strongly agreed with the myth statements. These results indicate a diversity of beliefs and attitudes towards genetic modification amongst those within the science community, and highlight the importance of understanding ethics and myths in dealing with them. It is suggested that the diversity of beliefs could be better used to help shape public policy and understanding of biotechnology.
Fisher
Mark
M
Small
Bruce
B
Roth
Hein
H
Mallon
Mary
M
Jerebine
Bryce
B
D000383:Agriculture; D000818:Animals; D001290:Attitude; D001690:Biological Science Disciplines; D002417:Cattle; D003625:Data Collection; D005818:Genetic Engineering / Q000941:ethics; D006801:Humans; D020407:Internet; D008892:Milk; D009103:Multiple Sclerosis / Q000188:drug therapy; D004676:Myelin Basic Protein; D009419:Nerve Tissue Proteins / Q000235:genetics / Q000627:therapeutic use; D030781:Organisms, Genetically Modified; D009938:Organizations; D014157:Transcription Factors / Q000235:genetics / Q000627:therapeutic use
C499048:MBP protein, human; D004676:Myelin Basic Protein; D009419:Nerve Tissue Proteins; D014157:Transcription Factors